Commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease-Reference-Cited by-同舟云学术

Commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease

Published:2013-12-17 Issue:1 Volume:19 Page:53-55
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Roberts Matthew A¹

Affiliation:

1. Department of Renal Medicine; Eastern Health Clinical School; Monash University; Melbourne Victoria Australia

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12168/fullpdf

Reference16 articles.

1. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: A systematic review and meta-analysis;Lv;Plos Med.,2012

2. Kidney disease: Improving global outcomes;Eckardt;Nat. Rev. Nephrol.,2009

3. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease;Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group;Kidney Int. (Suppl.),2012

4. Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference;Levin;Kidney Int.,2010

5. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Chobanian;Hypertension,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning radiomics based on ultrasound images for the assisted diagnosis of chronic kidney disease;Nephrology;2024-08-12

2. Underdiagnosed CKD in Geriatric Trauma Patients and Potent Prevention of Renal Impairment from Polypharmacy Risks through Individual Pharmacotherapy Management (IPM-III);Journal of Clinical Medicine;2023-07-07

3. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial;Trials;2023-05-30

4. Unilateral Nephrectomized SHR/NDmcr-cp Rat Shows a Progressive Decline of Glomerular Filtration With Tubular Interstitial Lesions;Physiological Research;2023-04-30

5. A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease;BMC Nephrology;2022-10-18